A rising multiple dose study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of orally administered SCH 900389 in healthy females (P07036)

A rising multiple dose study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of orally administered SCH 900389 in healthy females (P07036) - P07036

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON36461

Enrollment

Registered

2010-12-23

Start date

2011-03-01

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertility

Interventions

The study will start with a screening. At the screening a physical examination will take place, a few other standard medical assessments will be performed (ECG, Vital signs) and standard gynecologic

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Healthy female subjects

Exclusion criteria

Exclusion criteria: Clinical significant abnormalities at screening

Design outcomes

Primary

Measure	Time frame
To investigate the safety and tolerability of the test compound after multiple oral dose administration for up to14 days To investigate the pharmacodynamic effects of the test compound after multiple dose oral administration for up to 14 days	—

Secondary

Measure	Time frame
*To investigate the multiple dose pharmacokinetics of the test compound	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)